Polar Capital Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-350,000
| Closed | -$31M | – | 282 |
|
|
2023
Q3 | $31M | Sell |
350,000
-75,000
| -18% | -$6.64M | 0.23% | 110 |
|
|
2023
Q2 | $36.8M | Hold |
425,000
| – | – | 0.19% | 101 |
|
|
2023
Q1 | $41.3M | Buy |
425,000
+250,000
| +143% | +$24.3M | 0.27% | 93 |
|
|
2022
Q4 | $18.1M | Sell |
175,000
-50,000
| -22% | -$5.17M | 0.14% | 154 |
|
|
2022
Q3 | $19.1K | Hold |
225,000
| – | – | 0.12% | 147 |
|
|
2022
Q2 | $18.6K | Sell |
225,000
-275,000
| -55% | -$22.8K | 0.11% | 150 |
|
|
2022
Q1 | $38.6K | Buy |
500,000
+375,000
| +300% | +$28.9K | 0.17% | 104 |
|
|
2021
Q4 | $11K | Hold |
125,000
| – | – | 0.04% | 220 |
|
|
2021
Q3 | $9.66K | Hold |
125,000
| – | – | 0.04% | 232 |
|
|
2021
Q2 | $10.4K | Hold |
125,000
| – | – | 0.05% | 219 |
|
|
2021
Q1 | $9.44M | Sell |
125,000
-225,000
| -64% | -$17M | 0.06% | 210 |
|
|
2020
Q4 | $30.7M | Buy |
+350,000
| New | +$30.7M | 0.19% | 119 |
|